KP Tissue Inc (KPT)

Currency in CAD
9.40
-0.10(-1.05%)
Real-time Data·
High dividend Yield
KPT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.409.50
52 wk Range
7.549.69
Key Statistics
Bid/Ask
9.41 / 9.44
Prev. Close
9.5
Open
9.5
Day's Range
9.4-9.5
52 wk Range
7.54-9.69
Volume
12.67K
Average Volume (3m)
17.27K
1-Year Change
13.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KPT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.13
Upside
+7.71%
Members' Sentiments
Bearish
Bullish
ProTips
Pays a significant dividend to shareholders

KP Tissue Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

KP Tissue Inc Company Profile

KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments:Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under the Cashmere, SpongeTowels, Scotties, Purex, Bonterra, Metro, White Swan, White Cloud, Embassy, Satinelle, and Chalet brand names, as well as under private labels. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.

KP Tissue Inc Earnings Call Summary for Q3/2025

  • KP Tissue reported Q3 2025 EPS of $0.836, exceeding forecasts by 483.39%, with revenue of $561.1 million (+7.7% YoY) and adjusted EBITDA rising 30.4% YoY to $85.7 million.
  • The company's stock rose 1.27% following the earnings announcement, trading near its 52-week high of $9.69, despite net income declining to $14.6 million from $18 million YoY.
  • CEO Dino Bianco announced plans for a new state-of-the-art tissue plant in the U.S. with operations starting in 2028, aimed at serving the company's 'fast-growing U.S. business.'
  • Management expects Q4 2025 adjusted EBITDA to remain similar to Q3 levels, with a strategic focus on long-term market share growth rather than temporary gains.
  • The new tissue plant investment is estimated at $500 million, with management confirming the equity component will be funded through current resources.
Last Updated: 13/11/2025, 15:40
Read Full Transcript

Compare KPT to Peers and Sector

Metrics to compare
KPT
Peers
Sector
Relationship
P/E Ratio
21.5x16.6x12.2x
PEG Ratio
−0.79−0.010.03
Price/Book
1.4x2.5x1.5x
Price / LTM Sales
-1.8x0.9x
Upside (Analyst Target)
5.5%14.6%19.0%
Fair Value Upside
Unlock6.9%10.2%Unlock

Analyst Ratings

0 Buy
4 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 10.13
(+7.71% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.44%
Dividend Yield
7.58%
Industry Median 0.28%
Annualised payout
0.72
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
0.836 / 0.1433
Revenue / Forecast
561.15M / 557.83M
EPS Revisions
Last 90 days

KPT Income Statement

People Also Watch

172.30
BMO
-1.09%
11.02
WCP
+2.13%
76.66
TRP
+0.38%
65.25
CCA
-0.96%
67.12
EMA
-1.13%

FAQ

What Stock Exchange Does KP Tissue Inc Trade On?

KP Tissue Inc is listed and trades on the Toronto Stock Exchange stock exchange.

What Is the Stock Symbol for KP Tissue Inc?

The stock symbol for KP Tissue Inc is "KPT."

What Is the KP Tissue Inc (KPT) Afterhours Price Today? (Afterhours variable test: 0.00) Current Date: 14 Nov 2025

After hours price: 0.00. After hours price change (units): 0.00. Price change percentage: 0.00%

What Is the KP Tissue Inc Market Cap?

As of today, KP Tissue Inc market cap is 94.58M.

What Is KP Tissue Inc's Earnings Per Share (TTM)?

The KP Tissue Inc EPS (TTM) is 0.44.

When Is the Next KP Tissue Inc Earnings Date?

KP Tissue Inc will release its next earnings report on 04 Mar 2026.

From a Technical Analysis Perspective, Is KPT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has KP Tissue Inc Stock Split?

KP Tissue Inc has split 0 times.

How Many Employees Does KP Tissue Inc Have?

KP Tissue Inc has 2700 employees.

What is the current trading status of KP Tissue Inc (KPT)?

As of 14 Nov 2025, KP Tissue Inc (KPT) is trading at a price of 9.40, with a previous close of 9.50. The stock has fluctuated within a day range of 9.40 to 9.50, while its 52-week range spans from 7.54 to 9.69.

What Is KP Tissue Inc (KPT) Price Target According to Analysts?

The average 12-month price target for KP Tissue Inc is CAD10.125, with a high estimate of CAD10.5 and a low estimate of CAD10. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +7.71% Upside potential.

What Is the KPT After Hours Price?

KPT's last after hours stock price is 0.00, the stock has decreased by 0.00, or 0.00%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.